Compass Therapeutics, Inc. (CMPX) earnings
CMPX earnings moved a median of +0.52% by the close. Quarterly and annual CMPX reports and results, each read against the price at its own news timestamp. Back to the CMPX overview →
13 measured CMPX earnings events.
Where these CMPX earnings landedvs 13 measured CMPX earnings reactions
| Middle 50% of CMPX earnings reactions | 0.00% to +3.11% |
|---|---|
| Median reaction (to close) | +0.52% |
| Measured reactions | 13 |
Point-in-time · zero look-ahead
Half of the 13 CMPX earnings events with a measured close landed between +0.00% and +3.11%; 54% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Compass Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.85% | +5.03% | |
| Form 10-Q Compass Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.52% | +3.11% | |
| Form 10-Q Compass Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -2.83% | +0.52% | |
| Form 10-K Compass Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.08% | +0.00% | |
| Compass Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update | Press release | -0.26% | +0.00% | |
| Form 10-Q Compass Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.26% | +0.00% | |
| Form 10-Q Compass Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +3.68% | +22.79% | |
| Form 10-Q Compass Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +5.95% | |
| Form 10-K Compass Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -2.67% | |
| Form 10-Q Compass Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -2.84% | -7.49% | |
| Form 10-Q Compass Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +4.91% | +0.89% | |
| Form 10-Q Compass Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -2.92% | -8.77% | |
| Form 10-K Compass Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.69% | +2.75% |
Keep exploring
More CMPX: analyst actions → · SEC filings → · CMPX overview →